Relx PLC ADR (RELX), formerly Reed Elsevier Group, is an information and analytics technology firm based in the UK. Its three primary business segments include Science & Technology, Health & Medical, Risk & Business Analytics. These domains cater to the needs of professionals across sectors, specialising in digital and print publishing, risk management tools, decision tools, and analytics.
Relx operates internationally, with a significant presence in North America, Europe and Asia. Its business segment, Science & Technology, provides reliable information and analytics to scientists and engineers enabling effective research outcomes. With a deep understanding of the scientific community’s requirements, Relx caters to millions of users globally, enhancing scientific discovery and innovation.
Its Health and Medical segment supports healthcare professionals, research scholars, and students by providing advanced clinical decision tools, research platforms, e-learning, and scientific, technical and medical (STM) information tools.
The Risk & Business Analytics division is responsible for providing high-end data services, analytics, and decision tools to major financial institutions, insurers, multinational companies, governments, and institutions. Its solutions aid customers in handling different aspects of risk, improve their operations and profitability, and accomplish regulatory compliance effectively.
Relx PLC ADR prides itself on the consistent investment in technology to achieve outstanding customer experience. Its rigorous data analysis and real-world experience have led the innovation in the information and analytic industry. RELX has been recognized for its contribution to the high-quality information provided to the industries it serves.
The company is listed under the ticker symbol "RELX" on several stock exchanges, including the London and Amsterdam stock exchanges, as well as the New York Stock Exchange in the United States for its ADR (American Depositary Receipt).
Despite the impact of the pandemic, in 2020, Relx proved resilience by delivering stable revenue growth, showcasing the robustness of its business model. This global multinational has solid-enviable credentials and is well-positioned for future growth, based on its continued commitment to innovation, investment in technology, and impressive scope of operations.
In summary, Relx PLC ADR is a globally recognized information and analytics provider, providing pivotal and impactful services for a range of sectors. This customer-focused organization boasts of resilience, adaptability, and remarkable growth, making it an influential player in the tech and analytics industries.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
LexisNexis Risk Solutions, a unit of RELX, has launched "Know Your Agent" intelligence, designed to help government agencies detect AI agents interacting with their digital systems. This new capability, available through ThreatMetrix and BehavioSec products, aims to address the significant growth in agentic traffic observed in the first half of 2026. While the product targets a new government need and builds on existing offerings, the release does not disclose pricing, contract values, or customer commitments.
LexisNexis Risk Solutions, a unit of RELX, has launched "Know Your Agent" intelligence to help government agencies detect AI agents interacting with digital systems. This new capability, available through ThreatMetrix and BehavioSec products, addresses a 750% growth in agentic traffic observed in the first half of 2026. The release highlights the product's value in distinguishing AI agents from humans and conventional bots but does not disclose financial terms or customer commitments.
LexisNexis Risk Solutions, a part of RELX, has introduced Accurint One, a new platform designed for U.S. criminal justice agencies. This platform integrates data, partner data, agency information, analytics, and governed AI into a single investigative environment. The launch is presented as a product announcement, without disclosing specific financial terms or revenue figures.
This article provides an AI-generated analysis of Relx Plc (NASDAQ: RELX), indicating neutral near-term sentiment but strong mid-term sentiment that may be stalling. It presents three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal analysis and highlights compelling upside potential due to the absence of resistance levels above the current price.
RELX plc's stock experienced a 1.63% drop on October 28, 2026, closing at 2,891.00 GBp, though it remains in an uptrend with a 15.83% gain over one month. Technical indicators suggest a "HOLD (wait & see)" verdict, as the positive trend is supported by moving averages and MACD, but short-term momentum is fading, and the pullback occurred on thin volume. Key levels to watch are resistance at 3,039.00 and support at the 20-day average of 2,794.90.
Shares of RELX PLC (REL) dropped 1.63% to £28.91 on Wednesday, underperforming the broader market despite the FTSE 100 Index rising 0.07%. The company's stock closed 17.33% below its 52-week high of £34.97, which was achieved on October 29th.
UBS has increased its price target for RELX PLC to 3,780p from 3,600p and maintained its 'buy' rating, citing AI as a growth enabler rather than a threat. The broker noted strong momentum in RELX's operations, particularly the adoption of AI products in its insurance analytics and legal businesses, despite disruptions in its Middle East exhibitions segment. These developments suggest that investors are starting to view RELX more favorably regarding AI-related risks.
UBS analyst Jo Barnet-Lamb has increased the price target for RELX Plc. (REL:LN) (RELX) to GBP37.80. The article, published on October 26, 2026, is a premium-only piece that requires a subscription to StreetInsider.com Premium for full access.